封面
市場調查報告書
商品編碼
1619195

伴同性動物醫療市場規模、佔有率和成長分析(按產品類型、動物類型、最終用戶、分銷管道和地區):產業預測(2024-2031)

Companion Animal Healthcare Market Size, Share, Growth Analysis, By Product Type (Pharmaceuticals, Vaccines), By Animal Type (Dogs, Cats), By End User, By Distribution Channel, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年,全球伴同性動物保健市場規模為216億美元,從2023年的235.7億美元成長到2031年的473億美元,在預測期間(2024-2031年)預計複合年成長率為9.1%。

隨著遠距工作的激增,越來越多的人收養寵物來緩解孤獨和焦慮感。根據《歐洲寵物食品產業報告》,2022年,歐洲將飼養約3.4億隻伴同性動物,46%的家庭至少擁有一隻寵物。特別是在德國,據報道大約有1060萬隻狗和1520萬隻貓,顯示貓的擁有率很高。同時,寵物健康問題,特別是犬類癌症發生率的增加,凸顯了加強獸醫醫學的必要性。英國英國有顯著的癌症風險。公司正在擴大其市場佔有率,以滿足日益成長的寵物護理需求。 Inspire Veterinary Partners 於 2023 年 11 月收購 Valley Veterinary Service Inc. 就證明了這一點,增加了先進寵物護理設施的使用機會。

目錄

介紹

  • 分析目的
  • 市場範圍
  • 定義

分析方法

  • 資訊採購
  • 次要/主要資料方法
  • 市場規模預測
  • 市場假設與約束

執行摘要

  • 市場概況及展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及前景

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制因素和挑戰
  • 波特分析及影響
    • 競爭公司之間的敵對關係
    • 替代品的威脅
    • 買方議價能力
    • 新進入者的威脅
    • 供應商的議價能力

主要市場考慮因素

  • 關鍵成功因素
  • 競爭程度
  • 主要投資來源
  • 市場生態系統
  • 市場魅力指數(2023)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析
  • 技術進步
  • 監管環境
  • 專利分析
  • 案例研究

全球伴同性動物醫療市場規模與複合年成長率:按產品類型分類(2024-2031)

  • 市場概況
  • 藥品
    • 抗生素
    • 抗發炎藥
    • 寄生劑
    • 疼痛管理
    • 其他
  • 疫苗
    • 減毒活疫苗
    • 去活化疫苗
    • 重組疫苗
    • 其他
  • 診斷
    • 免疫診斷測試
    • 分子診斷
    • 診斷影像
    • 臨床化學
    • 其他
  • 飼料添加劑
    • 營養飼料添加劑
    • 藥物飼料添加劑

全球伴同性動物醫療市場規模/複合年成長率:按動物類型分類(2024-2031)

  • 市場概況
  • 其他

全球伴同性動物醫療市場規模與複合年成長率:按最終用戶分類(2024-2031)

  • 市場概況
  • 動物醫院/診所
  • 診斷實驗室
  • 研究所
  • 居家醫療

全球伴同性動物醫療市場規模與複合年成長率:按分銷管道分類(2024-2031)

  • 市場概況
  • 醫院藥房
  • 零售藥房
  • 網路藥房

全球伴同性動物醫療市場規模及複合年成長率(2024-2031)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要企業採取的策略
  • 近期市場趨勢
  • 主要企業市場佔有率(2023年)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2021-2023)

主要企業簡介

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Bayer AG
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol SA
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Ourofino Saude Animal
  • Neogen Corporation
  • Ceva Animal Health LLC

結論和建議

簡介目錄
Product Code: SQMIG35E2026

Global Companion Animal Healthcare Market size was valued at USD 21.60 billion in 2022 and is poised to grow from USD 23.57 billion in 2023 to USD 47.30 billion by 2031, growing at a CAGR of 9.1% during the forecast period (2024-2031).

The surge in remote work has catalyzed pet adoption, as individuals seek companionship to alleviate feelings of isolation and anxiety. According to the European Pet Food Industry report, Europe housed approximately 340 million companion animals in 2022, with 46% of households owning at least one pet. Notably, Germany reported around 10.6 million dogs and 15.2 million cats, indicating a higher adoption rate for cats. Concurrently, the rise in pet health concerns, particularly the increasing incidence of cancer in dogs, underscores the need for enhanced veterinary care. The Royal Veterinary College's June 2023 study highlighted significant cancer risks in UK dog breeds. To capitalize on the growing demand for pet care, companies are expanding their market presence, as evidenced by Inspire Veterinary Partners' acquisition of Valley Veterinary Service Inc. in November 2023, enhancing access to advanced pet healthcare facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Healthcare Market Segmental Analysis

Global Companion Animal Healthcare Market is segmented by product type, animal type, end user, distribution channel and region. Based on product type, the market is segmented into pharmaceuticals (antibiotics, anti-inflammatory drugs, parasiticides, pain management, others), vaccines (live attenuated vaccines, inactivated vaccines, recombinant vaccines, others), diagnostics (immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, others) and feed additives (nutritional feed additives, medicinal feed additives). Based on animal type, the market is segmented into dogs, cats, horses and other. Based on end user, the market is segmented into veterinary hospitals & clinics, diagnostic laboratories, research institutes and home care settings. Based on distribution channel, the market is segmented into Hospital Pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Companion Animal Healthcare Market

The global companion animal healthcare market is significantly driven by the rising trend of pet ownership worldwide. As more individuals embrace pets as companions, there is a corresponding surge in the demand for various health services, including veterinary care, vaccinations, and wellness products tailored for animals. This growth in pet ownership can be attributed to several factors, such as urban living conditions, evolving lifestyles, and heightened awareness of the numerous benefits associated with having pets. Ultimately, as more people bring pets into their homes, the need for comprehensive healthcare solutions for these animals continues to expand, fueling market growth.

Restraints in the Global Companion Animal Healthcare Market

One of the significant constraints in the Global Companion Animal Healthcare market is the rising cost of veterinary care. The expense associated with advanced treatments and procedures can be prohibitively high, impeding pet owners from accessing the full spectrum of healthcare options for their animals. This financial hurdle disproportionately affects low- and moderate-income pet owners, who may struggle to provide necessary medical care for their pets. As a result, the lack of affordability can lead to an inadequate healthcare experience, failing to meet the comprehensive needs of companion animals and limiting their overall health and well-being.

Market Trends of the Global Companion Animal Healthcare Market

The Global Companion Animal Healthcare market is witnessing a notable trend towards the increasing adoption of pet insurance, driven by a growing awareness among pet owners about the financial benefits of such coverage. As veterinary costs continue to rise, pet insurance provides a viable solution for managing expenses related to medical, surgical, and preventative care, alleviating financial stress for pet owners. This shift is further fueled by a heightened emphasis on the well-being of pets, prompting owners to seek comprehensive healthcare solutions. Consequently, this surge in pet insurance adoption is expected to significantly contribute to market growth and shape future healthcare strategies for companion animals.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Companion Animal Healthcare Market Size by Product Type & CAGR (2024-2031)

  • Market Overview
  • Pharmaceuticals
    • Antibiotics
    • Anti-inflammatory Drugs
    • Parasiticides
    • Pain Management
    • Others
  • Vaccines
    • Live Attenuated Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • Others
  • Diagnostics
    • Immunodiagnostic Tests
    • Molecular Diagnostics
    • Diagnostic Imaging
    • Clinical Chemistry
    • Others
  • Feed Additives
    • Nutritional Feed Additives
    • Medicinal Feed Additives

Global Companion Animal Healthcare Market Size by Animal Type & CAGR (2024-2031)

  • Market Overview
  • Dogs
  • Cats
  • Horses
  • Other

Global Companion Animal Healthcare Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Veterinary Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Home Care Settings

Global Companion Animal Healthcare Market Size by Distribution Channel & CAGR (2024-2031)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Companion Animal Healthcare Market Size & CAGR (2024-2031)

  • North America (Product Type, Animal Type, End User, Distribution Channel, Distribution Channel)
    • US
    • Canada
  • Europe (Product Type, Animal Type, End User, Distribution Channel)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Product Type, Animal Type, End User, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Product Type, Animal Type, End User, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Animal Type, End User, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Zoetis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim International GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco Animal Health Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva Sante Animale
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vetoquinol S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heska Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDEXX Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dechra Pharmaceuticals PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Phibro Animal Health Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ourofino Saude Animal
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva Animal Health LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation